{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:49:09Z","timestamp":1792687749190,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["J-PEAKS"],"award-info":[{"award-number":["J-PEAKS"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H02793"],"award-info":[{"award-number":["JP22H02793"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K18197"],"award-info":[{"award-number":["JP23K18197"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009035","name":"Program on Open Innovation Platform with Enterprises, Research Institute and Academia","doi-asserted-by":"publisher","award":["JPMXS0450200225"],"award-info":[{"award-number":["JPMXS0450200225"]}],"id":[{"id":"10.13039\/501100009035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21ak0101179"],"award-info":[{"award-number":["21ak0101179"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00216-025-06296-y","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:42:42Z","timestamp":1766526162000},"page":"6705-6719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["LC-MS\/MS and high-spatial single-cell MSI reveal selective downregulation of PC(16:0_16:0) and PC(18:0_18:1) due to mPGES-1 knockdown in hormone-resistant prostate cancer cell line"],"prefix":"10.1007","volume":"418","author":[{"given":"Mst. Sayela","family":"Afroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5842-6176","authenticated-orcid":false,"given":"Shuhei","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Muedur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Dubail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoka","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Kahyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumasa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"R\u00e5dmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutoshi","family":"Setou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Hanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"6296_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/CAAC.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/CAAC.21834.","journal-title":"CA Cancer J Clin"},{"key":"6296_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-04421-w","author":"AA Khorram","year":"2024","unstructured":"Khorram AA, Pourasgharian R, Shams AS, Toufani S, Mostafaei M, Khademi R, Daghayeghi R, Valifard M, shahrokhi M, Seyedipour S, Deravi N, Naziri M, Malek M, Bashir F. Androgen deprivation therapy use and the risk of heart failure in patients with prostate cancer: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2024. https:\/\/doi.org\/10.1186\/s12872-024-04421-w.","journal-title":"BMC Cardiovasc Disord"},{"key":"6296_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1053\/J.SEMINONCOL.2013.04.001","volume":"40","author":"R Schrecengost","year":"2013","unstructured":"Schrecengost R, Knudsen KE. Molecular pathogenesis and progression of prostate cancer. Semin Oncol. 2013;40:244\u201358. https:\/\/doi.org\/10.1053\/J.SEMINONCOL.2013.04.001.","journal-title":"Semin Oncol"},{"key":"6296_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.EURURO.2011.08.026","volume":"61","author":"V Pagliarulo","year":"2012","unstructured":"Pagliarulo V, Bracarda S, Eisenberger MA, Mottet N, Schr\u00f6der FH, Sternberg CN, Studer UE. Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol. 2012;61:11\u201325. https:\/\/doi.org\/10.1016\/J.EURURO.2011.08.026.","journal-title":"Eur Urol"},{"key":"6296_CR5","first-page":"101","volume":"9","author":"DR Miller","year":"2021","unstructured":"Miller DR, Ingersoll MA, Teply BA, Lin M-F. Targeting treatment options for castration-resistant prostate cancer. Am J Clin Exp Urol. 2021;9:101.","journal-title":"Am J Clin Exp Urol"},{"key":"6296_CR6","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/J.1742-1241.2011.02799.X","volume":"65","author":"M Kirby","year":"2011","unstructured":"Kirby M, Hirst C, Crawford ED. Characterising the castration-resistant prostate cancer population: a systematic review. Int J Clin Pract. 2011;65:1180\u201392. https:\/\/doi.org\/10.1111\/J.1742-1241.2011.02799.X.","journal-title":"Int J Clin Pract"},{"key":"6296_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12102984","volume":"12","author":"M Archer","year":"2020","unstructured":"Archer M, Dogra N, Kyprianou N. Inflammation as a driver of prostate cancer metastasis and therapeutic resistance. Cancers (Basel). 2020;12:1\u201324.","journal-title":"Cancers (Basel)"},{"key":"6296_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126\/104494\/P\/CHRONIC-INFLAMMATION-IN-BENIGN-PROSTATE-TISSUE-IS","volume":"23","author":"B Gurel","year":"2014","unstructured":"Gurel B, Lucia MS, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomark Prev. 2014;23:847\u201356. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-1126\/104494\/P\/CHRONIC-INFLAMMATION-IN-BENIGN-PROSTATE-TISSUE-IS.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6296_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/J.CANLET.2010.03.015","volume":"295","author":"WKK Wu","year":"2010","unstructured":"Wu WKK, Yiu Sung JJ, Lee CW, Yu J, Cho CH. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett. 2010;295:7\u201316. https:\/\/doi.org\/10.1016\/J.CANLET.2010.03.015.","journal-title":"Cancer Lett"},{"key":"6296_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0090-6980(99)90251-4","volume":"59","author":"PJ Jakobsson","year":"1999","unstructured":"Jakobsson PJ, Thor\u00e9n S, Morgenstern R, Samuelsson B. Prostaglandin E synthase: a microsomal, glutathione dependent, inducible member of the MAPEG superfamily. Prostaglandins Other Lipid Mediat. 1999;59:16. https:\/\/doi.org\/10.1016\/S0090-6980(99)90251-4.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"6296_CR11","doi-asserted-by":"publisher","first-page":"7750","DOI":"10.1158\/0008-5472.CAN-07-6689","volume":"68","author":"S Jain","year":"2008","unstructured":"Jain S, Chakraborty G, Raja R, Kale S, Kundu GC. Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res. 2008;68:7750\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6689.","journal-title":"Cancer Res"},{"key":"6296_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/PR.59.3.1","volume":"59","author":"B Samuelsson","year":"2007","unstructured":"Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev. 2007;59:207\u201324. https:\/\/doi.org\/10.1124\/PR.59.3.1.","journal-title":"Pharmacol Rev"},{"key":"6296_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/aje\/kwq175","volume":"172","author":"CA Salinas","year":"2010","unstructured":"Salinas CA, Kwon EM, Fitzgerald LM, Feng Z, Nelson PS, Ostrander EA, Peters U, Stanford JL. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. Am J Epidemiol. 2010;172:578\u201390. https:\/\/doi.org\/10.1093\/aje\/kwq175.","journal-title":"Am J Epidemiol"},{"key":"6296_CR14","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/cam4.1186","volume":"6","author":"S Doat","year":"2017","unstructured":"Doat S, C\u00e9n\u00e9e S, Tr\u00e9tarre B, Rebillard X, Lamy PJ, Bringer JP, Iborra F, Murez T, Sanchez M, Menegaux F. Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study. Cancer Med. 2017;6:2461\u201370. https:\/\/doi.org\/10.1002\/cam4.1186.","journal-title":"Cancer Med"},{"key":"6296_CR15","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1074\/JBC.M213290200","volume":"278","author":"D Kamei","year":"2003","unstructured":"Kamei D, Murakami M, Nakatani Y, Ishikawa Y, Ishii T, Kudo I. Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J Biol Chem. 2003;278:19396\u2013405. https:\/\/doi.org\/10.1074\/JBC.M213290200.","journal-title":"J Biol Chem"},{"key":"6296_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/AR1748\/FIGURES\/2","volume":"7","author":"AV Sampey","year":"2005","unstructured":"Sampey AV, Monrad S, Crofford LJ. Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2. Arthritis Res Ther. 2005;7:114\u20137. https:\/\/doi.org\/10.1186\/AR1748\/FIGURES\/2.","journal-title":"Arthritis Res Ther"},{"key":"6296_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254315","volume":"16","author":"X Jiang","year":"2021","unstructured":"Jiang X, Renkema H, Smeitink J, Beyrath J. Sonlicromanol\u2019s active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth. PLoS One. 2021;16: e0254315. https:\/\/doi.org\/10.1371\/journal.pone.0254315.","journal-title":"PLoS One"},{"key":"6296_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13092000","volume":"13","author":"M Buszewska-forajta","year":"2021","unstructured":"Buszewska-forajta M, Pomastowski P, Monedeiro F, Walczak-skierska J, Markuszewski M, Matuszewski M, Markuszewski MJ, Buszewski B. Lipidomics as a diagnostic tool for prostate cancer. Cancers (Basel). 2021;13:1\u201320. https:\/\/doi.org\/10.3390\/cancers13092000.","journal-title":"Cancers (Basel)"},{"key":"6296_CR19","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1194\/jlr.M009449","volume":"51","author":"O Quehenberger","year":"2010","unstructured":"Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, Bandyopadhyay S, Jones KN, Kelly S, Shaner RL, Sullards CM, Wang E, Murphy RC, Barkley RM, Leiker TJ, Raetz CRH, Guan Z, Laird GM, Six DA, Russell DW, McDonald JG, Subramaniam S, Fahy E, Dennis EA. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010;51:3299\u2013305. https:\/\/doi.org\/10.1194\/jlr.M009449.","journal-title":"J Lipid Res"},{"key":"6296_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0006-291X(03)01023-4","volume":"306","author":"K Minamiguchi","year":"2003","unstructured":"Minamiguchi K, Kawada M, Someno T, Ishizuka M. Androgen-independent prostate cancer DU145 cells suppress androgen-dependent growth of prostate stromal cells through production of inhibitory factors for androgen responsiveness. Biochem Biophys Res Commun. 2003;306:629\u201336. https:\/\/doi.org\/10.1016\/S0006-291X(03)01023-4.","journal-title":"Biochem Biophys Res Commun"},{"key":"6296_CR21","doi-asserted-by":"publisher","first-page":"18757","DOI":"10.1073\/pnas.0910218106","volume":"106","author":"H Hanaka","year":"2009","unstructured":"Hanaka H, Pawelzik SC, Johnsen JI, Rakonjac M, Terawaki K, Rasmuson A, Sveinbj\u00f6rnsson B, Schumacher MC, Hamberg M, Samuelsson B, Jakobsson PJ, Kogner P, R\u00e5dmark O. Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells. Proc Natl Acad Sci U S A. 2009;106:18757\u201362. https:\/\/doi.org\/10.1073\/pnas.0910218106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6296_CR22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/14789450.2020.1880897","volume":"17","author":"A Mamun","year":"2020","unstructured":"Mamun A, Islam A, Eto F, Sato T, Kahyo T, Setou M. Mass spectrometry-based phospholipid imaging: methods and findings. Expert Rev Proteomics. 2020;17:843\u201354. https:\/\/doi.org\/10.1080\/14789450.2020.1880897.","journal-title":"Expert Rev Proteomics"},{"key":"6296_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1021\/jasms.4c00045","volume":"35","author":"MM Rahman","year":"2024","unstructured":"Rahman MM, Islam A, Mamun MA, Afroz MS, Nabi MM, Sakamoto T, Sato T, Kahyo T, Takahashi Y, Okino A, Setou M. Low-temperature plasma pretreatment enhanced cholesterol detection in brain by desorption electrospray ionization-mass spectrometry imaging. J Am Soc Mass Spectrom. 2024;35:1227\u201336. https:\/\/doi.org\/10.1021\/jasms.4c00045.","journal-title":"J Am Soc Mass Spectrom"},{"key":"6296_CR24","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00216-011-4909-3","volume":"400","author":"J Matsumoto","year":"2011","unstructured":"Matsumoto J, Sugiura Y, Yuki D, Hayasaka T, Goto-Inoue N, Zaima N, Kunii Y, Wada A, Yang Q, Nishiura K, Akatsu H, Hori A, Hashizume Y, Yamamoto T, Ikemoto K, Setou M, Niwa SI. Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption\/ionization imaging mass spectrometry. Anal Bioanal Chem. 2011;400:1933\u201343. https:\/\/doi.org\/10.1007\/s00216-011-4909-3.","journal-title":"Anal Bioanal Chem"},{"key":"6296_CR25","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1021\/ac970888i","volume":"69","author":"RM Caprioli","year":"1997","unstructured":"Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem. 1997;69:4751\u201360. https:\/\/doi.org\/10.1021\/ac970888i.","journal-title":"Anal Chem"},{"key":"6296_CR26","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/nprot.2011.388","volume":"6","author":"R Casadonte","year":"2011","unstructured":"Casadonte R, Caprioli RM. Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry. Nat Protoc. 2011;6:1695\u2013709. https:\/\/doi.org\/10.1038\/nprot.2011.388.","journal-title":"Nat Protoc"},{"key":"6296_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1021\/JASMS.4C00435","volume":"36","author":"TV Palomino","year":"2025","unstructured":"Palomino TV, Muddiman DC. Glycosaminoglycan mass spectrometry imaging by infrared matrix-assisted laser desorption electrospray ionization. J Am Soc Mass Spectrom. 2025;36:658\u201363. https:\/\/doi.org\/10.1021\/JASMS.4C00435.","journal-title":"J Am Soc Mass Spectrom"},{"key":"6296_CR28","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/jasms.3c00149","volume":"34","author":"MM Al","year":"2023","unstructured":"Al MM, Rahman MM, Sakamoto T, Islam A, Oyama S, Nabi MM, Sato T, Kahyo T, Takahashi Y, Setou M. Detection of distinct distributions of acetaminophen and acetaminophen-cysteine in kidneys up to 10 \u03bcm resolution and identification of a novel acetaminophen metabolite using an AP-MALDI imaging mass microscope. J Am Soc Mass Spectrom. 2023;34:1491\u2013500. https:\/\/doi.org\/10.1021\/jasms.3c00149.","journal-title":"J Am Soc Mass Spectrom"},{"key":"6296_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094840","author":"MM Islam","year":"2024","unstructured":"Islam MM, Rahman MF, Islam A, Afroz MS, Mamun MA, Rahman MM, Maniruzzaman M, Xu L, Sakamoto T, Takahashi Y, Sato T, Kahyo T, Setou M. Elucidating gender-specific distribution of imipramine, chloroquine, and their metabolites in mice kidney tissues through AP-MALDI-MSI. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25094840.","journal-title":"Int J Mol Sci"},{"key":"6296_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/J.TALANTA.2024.127460","volume":"286","author":"L Mavroudakis","year":"2025","unstructured":"Mavroudakis L, Golubova A, Lanekoff I. Spatial metabolomics platform combining mass spectrometry imaging and in-depth chemical characterization with capillary electrophoresis. Talanta. 2025;286: 127460. https:\/\/doi.org\/10.1016\/J.TALANTA.2024.127460.","journal-title":"Talanta"},{"key":"6296_CR31","doi-asserted-by":"publisher","first-page":"e5148","DOI":"10.1002\/JMS.5148","volume":"60","author":"MM Rahman","year":"2025","unstructured":"Rahman MM, Afroz MS, Mamun MA, Islam A, Sakamoto T, Aramaki S, Sato T, Paxton T, Takahashi Y, Kahyo T, Setou M. Quantitative mass spectrometry imaging by targeted-DESI-MSI in MRM mode provides higher sensitivity and specificity for fast quantification of chloroquine drug in mice kidney. J Mass Spectrom. 2025;60:e5148. https:\/\/doi.org\/10.1002\/JMS.5148.","journal-title":"J Mass Spectrom"},{"key":"6296_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biology12030395","volume":"12","author":"S Lee","year":"2023","unstructured":"Lee S, Vu HM, Lee JH, Lim H, Kim MS. Advances in mass spectrometry-based single cell analysis. Biology (Basel). 2023;12:1\u201327. https:\/\/doi.org\/10.3390\/biology12030395.","journal-title":"Biology (Basel)"},{"key":"6296_CR33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41592-019-0536-2","volume":"16","author":"M Niehaus","year":"2019","unstructured":"Niehaus M, Soltwisch J, Belov ME, Dreisewerd K. Transmission-mode MALDI-2 mass spectrometry imaging of cells and tissues at subcellular resolution. Nat Methods. 2019;16:925\u201331. https:\/\/doi.org\/10.1038\/s41592-019-0536-2.","journal-title":"Nat Methods"},{"key":"6296_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-40512-6","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Liu Y, Fields L, Shi X, Huang P, Lu H, Schneider AJ, Tang X, Puglielli L, Welham NV, Li L. Single-cell lipidomics enabled by dual-polarity ionization and ion mobility-mass spectrometry imaging. Nat Commun. 2023;14:1\u201311. https:\/\/doi.org\/10.1038\/s41467-023-40512-6.","journal-title":"Nat Commun"},{"key":"6296_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nmeth.4071","volume":"14","author":"M Kompauer","year":"2016","unstructured":"Kompauer M, Heiles S, Spengler B. Atmospheric pressure MALDI mass spectrometry imaging of tissues and cells at 1.4-\u03bcm lateral resolution. Nat Methods. 2016;14:90\u20136. https:\/\/doi.org\/10.1038\/nmeth.4071.","journal-title":"Nat Methods"},{"key":"6296_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111314","author":"A Islam","year":"2022","unstructured":"Islam A, Sakamoto T, Zhai Q, Rahman MM, Mamun MA, Takahashi Y, Kahyo T, Setou M. Application of AP-MALDI imaging mass microscope for the rapid mapping of imipramine, chloroquine, and their metabolites in the kidney and brain of wild-type mice. Pharmaceuticals. 2022. https:\/\/doi.org\/10.3390\/ph15111314.","journal-title":"Pharmaceuticals"},{"key":"6296_CR37","doi-asserted-by":"publisher","unstructured":"Bligh, E. G., & Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 37(8), 911\u2013917. https:\/\/doi.org\/10.1139\/o59-099.","DOI":"10.1139\/o59-099"},{"key":"6296_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/app14103978","author":"SA Rimi","year":"2024","unstructured":"Rimi SA, Alam MJ, Kristof J, Sadiq AH, Hasan M, Mamun MA, et al. Lipidomics of microplasma-irradiated cells at optimized discharge conditions for the absorption of high-molecule drug. Appl Sci. 2024. https:\/\/doi.org\/10.3390\/app14103978.","journal-title":"Appl Sci"},{"key":"6296_CR39","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4155\/FMC.13.107","volume":"5","author":"J Liu","year":"2013","unstructured":"Liu J, Beckman BS, Foroozesh M. A review of ceramide analogs as potential anticancer agents. Future Med Chem. 2013;5:1405\u201321. https:\/\/doi.org\/10.4155\/FMC.13.107.","journal-title":"Future Med Chem"},{"key":"6296_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1464-410X.2011.10358.x","volume":"109","author":"N Hayashi","year":"2012","unstructured":"Hayashi N, Matsushima M, Yamamoto T, Sasaki H, Takahashi H, Egawa S. The impact of hypertriglyceridemia on prostate cancer development in patients aged \u226560 years. BJU Int. 2012;109:515\u20139. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10358.x.","journal-title":"BJU Int"},{"key":"6296_CR41","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1158\/1055-9965.EPI-14-0458\/350317\/P\/SERUM-LIPID-PROFILE-AND-RISK-OF-PROSTATE-CANCER","volume":"23","author":"EH Allott","year":"2014","unstructured":"Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, et al. Serum lipid profile and risk of prostate cancer recurrence: results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2014;23:2349\u201356. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0458\/350317\/P\/SERUM-LIPID-PROFILE-AND-RISK-OF-PROSTATE-CANCER.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6296_CR42","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/ijc.30903","volume":"141","author":"HM Lin","year":"2017","unstructured":"Lin HM, Mahon KL, Weir JM, Mundra PA, Spielman C, Briscoe K, et al. A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer. Int J Cancer. 2017;141:2112\u201320. https:\/\/doi.org\/10.1002\/ijc.30903.","journal-title":"Int J Cancer"},{"key":"6296_CR43","doi-asserted-by":"publisher","first-page":"675.1","DOI":"10.1096\/FASEBJ.2019.33.1_SUPPLEMENT.675.1","volume":"33","author":"LM Ingram","year":"2019","unstructured":"Ingram LM, Mansoura M, Cummings BS. Phospholipids as indicators of docetaxel-resistant castration-resistant prostate cancer. FASEB J. 2019;33:675.1-675.1. https:\/\/doi.org\/10.1096\/FASEBJ.2019.33.1_SUPPLEMENT.675.1.","journal-title":"FASEB J"},{"key":"6296_CR44","doi-asserted-by":"publisher","first-page":"e2114365119","DOI":"10.1073\/PNAS.2114365119\/-\/DCSUPPLEMENTAL","volume":"119","author":"T Bien","year":"2022","unstructured":"Bien T, Koerfer K, Schwenzfeier J, Dreisewerd K, Soltwisch J. Mass spectrometry imaging to explore molecular heterogeneity in cell culture. Proc Natl Acad Sci U S A. 2022;119:e2114365119. https:\/\/doi.org\/10.1073\/PNAS.2114365119\/-\/DCSUPPLEMENTAL.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6296_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBCAN.2020.188421","volume":"1874","author":"Y Tong","year":"2020","unstructured":"Tong Y, Gao WQ, Liu Y. Metabolic heterogeneity in cancer: an overview and therapeutic implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2020;1874:188421. https:\/\/doi.org\/10.1016\/J.BBCAN.2020.188421.","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"6296_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jms.4798","volume":"56","author":"A Kotnala","year":"2021","unstructured":"Kotnala A, Anderson DMG, Patterson NH, Cantrell LS, Messinger JD, Curcio CA, et al. Tissue fixation effects on human retinal lipid analysis by MALDI imaging and LC-MS\/MS technologies. J Mass Spectrom. 2021;56:e4798. https:\/\/doi.org\/10.1002\/jms.4798.","journal-title":"J Mass Spectrom"},{"key":"6296_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2023.106738","volume":"167","author":"J Liu","year":"2023","unstructured":"Liu J, Peng B, Steinmetz-Sp\u00e4h J, Idborg H, Korotkova M, Jakobsson PJ (2023) Microsomal prostaglandin E synthase-1 inhibition promotes shunting in arachidonic acid metabolism during inflammatory responses in vitro. Prostaglandins Other Lipid Mediat 167: doi: 10.1016\/j.prostaglandins.2023.106738.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"6296_CR48","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1096\/FJ.07-103457","volume":"22","author":"B Sveinbj\u00f6rnsson","year":"2008","unstructured":"Sveinbj\u00f6rnsson B, Rasmuson A, Baryawno N, Wan M, Pettersen I, Ponthan F, et al. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. FASEB J. 2008;22:3525\u201336. https:\/\/doi.org\/10.1096\/FJ.07-103457.","journal-title":"FASEB J"},{"key":"6296_CR49","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/J.BBRC.2005.01.072","volume":"328","author":"EM Choi","year":"2005","unstructured":"Choi EM, Heo JI, Oh JY, Kim YM, Ha KS, Kim JI, et al. COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis. Biochem Biophys Res Commun. 2005;328:1107\u201312. https:\/\/doi.org\/10.1016\/J.BBRC.2005.01.072.","journal-title":"Biochem Biophys Res Commun"},{"key":"6296_CR50","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1038\/SJ.ONC.1210391","volume":"26","author":"TM Covey","year":"2007","unstructured":"Covey TM, Edes K, Fitzpatrick FA. Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor. Oncogene. 2007;26:5784\u201392. https:\/\/doi.org\/10.1038\/SJ.ONC.1210391.","journal-title":"Oncogene"},{"key":"6296_CR51","doi-asserted-by":"crossref","unstructured":"Microsomal prostaglandin E synthase\u20101 and 5\u2010lipoxygenase: potential drug targets in cancer - R\u00e5dmark - 2010 - Journal of Internal Medicine - Wiley Online Library. https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2010.02246.x. Accessed 17 Jun 2025","DOI":"10.1111\/j.1365-2796.2010.02246.x"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-06296-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-025-06296-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-06296-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:02:38Z","timestamp":1790636558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-025-06296-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":51,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["6296"],"URL":"https:\/\/doi.org\/10.1007\/s00216-025-06296-y","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}